Core Laboratories Net Worth

Core Laboratories Net Worth Analysis

Core Laboratories Target Price Consensus

Core Laboratories Target Price Projection

Core Laboratories' current and average target prices are 17.75 and 19.33, respectively. The current price of Core Laboratories is the price at which Core Laboratories NV is currently trading. On the other hand, Core Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Core Laboratories NV and the information provided on this page.

Know Core Laboratories' Top Institutional Investors

Note, although Core Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Core Laboratories' market capitalization trends

The company currently falls under 'Small-Cap' category with a total capitalization of 833.36 M.

Project Core Laboratories' profitablity

The company has Net Profit Margin of 0.05 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.12 %, which entails that for every 100 dollars of revenue, it generated $0.12 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Core Laboratories' management efficiency

Core Laboratories has Return on Asset of 0.0589 % which means that on every $100 spent on assets, it made $0.0589 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1116 %, implying that it generated $0.1116 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At present, Core Laboratories' Return On Assets are projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 0.32, whereas Return On Tangible Assets are forecasted to decline to 0.07. At present, Core Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.

Core Laboratories Corporate Filings

Core Laboratories time-series forecasting models is one of many Core Laboratories' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Core Laboratories Earnings Estimation Breakdown

The calculation of Core Laboratories' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Core Laboratories is estimated to be 0.2067 with the future projection ranging from a low of 0.18 to a high of 0.23. Please be aware that this consensus of annual earnings estimates for Core Laboratories NV is based on EPS before non-recurring items and includes expenses related to employee stock options.

Core Laboratories Earnings Projection Consensus

Core Laboratories Earnings History

Earnings estimate consensus by Core Laboratories analysts from Wall Street is used by the market to judge Core Laboratories' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Core Laboratories' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. At present, Core Laboratories' Retained Earnings are projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 37.27, whereas Retained Earnings Total Equity is forecasted to decline to about 73.5 M. As of January 31, 2025, Common Stock Shares Outstanding is expected to decline to about 40.8 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 21.3 M.

Hype Prediction Low Estimated High 15.00 17.73 20.46 Details

Intrinsic Valuation Low Real High 14.13 16.86 19.59 Details

Naive Forecast Low Next High 14.34 17.07 19.81 Details

6 Analysts Consensus Low Target High 17.59 19.33 21.46 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Core assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Core Laboratories. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Core Laboratories' stock price in the short term.

Core Laboratories Earnings per Share Projection vs Actual

Actual Earning per Share of Core Laboratories refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Core Laboratories NV predict the company's earnings will be in the future. The higher the earnings per share of Core Laboratories, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Core Laboratories Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Core Laboratories, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Core Laboratories should always be considered in relation to other companies to make a more educated investment decision.

Core Quarterly Analyst Estimates and Surprise Metrics

Core Laboratories Corporate Management

When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:

How To Invest In Core Details

Is Core Stock a good investment? Details

What is Core Laboratories' Net Worth? Details

Largest Oil & Gas Equipment & Services Companies View

Largest Energy Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details